By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.

The Voice of People With Breast Cancer

Education

Educational Events

Workshop: Deconstructing Clinical Trials

Join us for a workshop designed to bring clarity to clinical trial research terms, led by Dr. Jan-Willem Henning, MD, FRCPC, a seasoned oncologist with extensive experience in breast cancer trials. This session will introduce patients to key terms—such as control arms, adverse events, survival rates, and response measures—in a way that bridges scientific language with practical understanding. Attendees will gain confidence in interpreting study results, making it easier to engage with their care team and make informed decisions.

Expert Speaker:
Dr. Jan-Willem Henning is a Clinical Associate Professor and Medical Oncologist at the Arthur Child Comprehensive Cancer Centre in Calgary Alberta and Cumming School of Medicine, University of Calgary. He received his medical degree (MBChB) in 1999 from the University of Orange Free State, South Africa and after immigrating to Canada; he received his certification of specialty training in Internal Medicine and Medical Oncology at the Royal College of Canada (FRCPC). His areas of clinical expertise include Breast Cancer, Sarcoma and Adolescent and Young Adult (AYA) Oncology. Dr. Henning is the immediate past program director for the medical oncology residency program in Calgary, and currently serves as the chair-elect for the Royal College Subspecialty Training Program for Medical Oncology. His research interest includes leading phase I-III clinical trials as well as health services research in AYA-oncology, Breast Cancer and Sarcoma. Dr. Henning is the current chair for the REAL (Research Excellence, Active Leadership) Canadian Breast Cancer Alliance. He has published in several international peer-reviewed journals, including the Lancet of Oncology.

When:

Where:

Who:

Key Topic(s):

January 22nd, 4:00PM EST

ONLINE

  • Breast cancer patients
  • Their caregivers & family
  • Decipher complex terms like efficacy, overall survival, and statistical significance.
  • Understand the difference between primary and secondary endpoints.
  • Explore real-world examples and apply learnings to study articles and reports.

To register click here.

SHARE

Financial
Navigator

Your path to accessing financial resources

Quick Find

Our Stories

Events

See our calendar